David L Earnest Selected Research

Stroke (Strokes)

6/2010

Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Earnest Research Topics

Disease

4	Diarrhea 01/2019 - 08/2008
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 06/2010
3	Abdominal Pain (Pain, Abdominal) 01/2020 - 11/2006
3	Constipation 01/2020 - 11/2006
2	Dyspepsia (Indigestion) 03/2010 - 08/2008
2	Carcinogenesis 05/2004 - 03/2003
1	Stroke (Strokes) 06/2010
1	Headache (Headaches) 11/2006
1	Ischemic Colitis 11/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2004
1	Polyps 03/2003
1	Adenomatous Polyps 03/2003
1	Adenoma (Adenomas) 03/2003
1	Neoplasms (Cancer) 06/2002
1	Aberrant Crypt Foci 06/2002

Drug/Important Bio-Agent (IBA)

4	alosetron (Lotronex)FDA Link 01/2020 - 01/2016
4	tegaserod (Zelnorm)FDA Link 06/2010 - 11/2006
2	Rifaximin (L 105)FDA Link 01/2020 - 01/2016
2	Bile Acids and Salts (Bile Acids)IBA 05/2004 - 03/2003
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 05/2004 - 06/2002
1	ramosetron (Nasea)IBA 01/2020
1	eluxadolineIBA 01/2016
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 05/2004
1	Dietary Fiber FDA Link 03/2003
1	dolichos biflorus agglutininIBA 06/2002
1	LectinsIBA 06/2002
1	NAD (NADH)IBA 06/2002

Therapy/Procedure

2	Therapeutics 01/2018 - 08/2008
1	Drug Therapy (Chemotherapy) 01/2019
1	Cholecystectomy 07/2004